Valneva SE American Depositary Shares (VALN)

About VALN

Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera or heat-labile toxin producing entero…

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Employees

674

Website

valneva.com/

Fundamentals

1-day range

$5.22$5.37

Market cap

$491.51M

P/E (trailing)

—

P/E (forward)

5.10

EPS (trailing)

$-1.09

Dividend yield

—

Beta

1.94

Avg. volume

29.7K

Forecasts

4 analyst ratings

Valneva SE American Depositary Shares Competitors

Chosen by industry and closest market cap.

• VALN

  Valneva SE American Depositary Shares

  $6.43

  ▼ 2.13%
  Market cap $491.51MP/E —
  $2.03$5.34
• PROK

  ProKidney Corp. Class A Ordinary Shares

  $1.84

  ▲ 1.10%
  Market cap $495.38MP/E —
  $1.3$3.48
• KYTX

  Kyverna Therapeutics Inc. Common Stock

  $8.36

  ▼ 3.24%
  Market cap $456.57MP/E —
  $3.55$13.67
• DNA

  Ginkgo Bioworks Holdings Inc. Class A Common Stock

  $6.98

  ▼ 3.93%
  Market cap $528.15MP/E —
  $5.37$17.58
• AUTL

  Autolus Therapeutics plc American Depositary Share

  $2.34

  ▼ 1.06%
  Market cap $532.31MP/E —
  $1.18$2.58
• PRME

  Prime Medicine Inc. Common Stock

  $3.62

  ▼ 0.69%
  Market cap $532.82MP/E —
  $2.67$6.94
• CABA

  Cabaletta Bio Inc. Common Stock

  $3.11

  ▼ 7.99%
  Market cap $450.03MP/E —
  $1.4$4.23

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
  benzinga · 8/25/2026
• Valneva: The Lyme Royalty Transition Changes The Earnings Model
  SeekingAlpha · 8/17/2026
• European Regulator Validates Pfizer and Valneva's Lyme Disease Vaccine Application
  Benzinga · 8/14/2026
• Dow Falls Over 100 Points; US Consumer Sentiment Declines In August
  Benzinga · 8/14/2026
• Heartflow, Eton Pharmaceuticals, Nu Holdings And Other Big Stocks Moving Higher On Friday
  Benzinga · 8/14/2026
• 12 Health Care Stocks Moving In Friday's Pre-Market Session
  Benzinga · 8/14/2026
• Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
  Benzinga · 8/14/2026
• Valneva SE 2026 Q2 - Results - Earnings Call Presentation
  SeekingAlpha · 8/14/2026
• Valneva SE (VALN) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/13/2026

Institutional Ownership

March 31, 2026

Total shares held

3.91M

Total value held

$24.30M

Institutional holders

21